Gillian Science

Gilead Sciences is a leading biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. The company's primary focus areas include HIV/AIDS, liver diseases, hematology, oncology, and inflammation/respiratory diseases. Gilead is widely recognized for transforming the treatment of HIV and Hepatitis C with highly effective antiviral therapies and has significantly expanded its oncology portfolio through strategic acquisitions like Kite Pharma and Immunomedics. Today, the company maintains a robust commercial portfolio and a deep clinical pipeline spanning multiple therapeutic modalities.